Book an Appointment

Prevention Is a Measurement Problem We’ve Been Solving Backwards

There’s a quiet irony in how most preventive care works. We wait for a number to cross a line — fasting glucose, blood pressure, LDL — and then we intervene. By the time the line is crossed, the process we were trying to prevent has often been underway for years. Prevention, done at the threshold, is really just early treatment.

The more useful question is whether we can see the trajectory before the threshold. Increasingly, we can. Fasting insulin and a calculated HOMA-IR can reveal insulin resistance long before glucose rises — sometimes the better part of a decade earlier. In cardiovascular risk, ApoB and lipoprotein(a) are giving us a sharper picture of arterial plaque risk than LDL alone, and major bodies have begun recommending that some of these be measured at least once in adulthood. None of this is exotic. Much of it is simply not yet routine.

Three pillars, because the body keeps the score in three places

If you strip longevity science down to what reliably moves outcomes, three things remain: reducing visceral fat, building and maintaining muscle, and improving cardiovascular fitness. They aren’t glamorous, and that’s precisely why they’re under-sold — there’s no product to hand across a counter. But they map almost one-to-one onto the conditions most likely to shorten or degrade a life: cardiovascular disease, metabolic disease, cancer, and neurodegeneration.

Visceral fat deserves special attention because it hides from the tools patients trust most. It isn’t the subcutaneous fat someone can pinch; it wraps the organs and the coronary arteries, it’s metabolically inflammatory, and it disrupts the hormonal environment — to the point that a meaningful share of a patient’s testosterone can be converted by adipose tissue, which is why fat loss alone sometimes restores levels that looked clinically low. A scale won’t show any of this. A DEXA scan will, in a few minutes, and it can sit in a clinic like another vital sign.

Cardiorespiratory fitness is a clinical variable, not a hobby

VO2 max is one of the strongest predictors of all-cause mortality we have, and it has become measurable outside a university lab. What’s clinically interesting isn’t just the headline number but the training zones it yields. Formula-derived zones, built off age alone, can be badly wrong — it’s entirely possible for a patient’s true Zone 2 to sit well above the estimate, which means a formula-guided plan would leave them chronically under-dosed. Measurement turns a guess into a prescription.

The mechanism is worth keeping in front of patients because it generalizes: better oxygen delivery improves tissue health everywhere, including the brain, where a large share of dementia is vascular. The same blood supply that determines whether a tendon heals determines whether neural tissue is perfused. Cardiovascular fitness is not a separate domain from the musculoskeletal work we already do — it’s upstream of it.

Strength training only counts when it asks the body to change

The most common strength-training error in older populations isn’t intensity — it’s the absence of it. Muscle is expensive tissue the body is reluctant to build, so adaptation requires genuine challenge: the set has to approach failure for the stimulus to register. “Three sets of ten” is only meaningful if the eighth rep is hard and the tenth is very hard. A set that could have continued for thirty reps hasn’t asked the body for anything. The good news is that this can be coached safely with machines and tools, without maximal loading.

Protein and creatine are the support structure, not the intervention. Most patients are under-dosing protein substantially — a palm of chicken is roughly twenty-five grams, and realistic targets land far higher than people expect. Creatine, often misunderstood as a shortcut, does no building on its own; it simply enables enough hard work to drive the adaptation, with emerging — not yet established — research on cognitive benefits.

What this changes in practice

The clinical posture that follows is less about prescribing more and more about measuring earlier and coaching better. It means having a lower threshold to look at ApoB or Lp(a), being willing to use a DEXA or a VO2 max as routine data rather than specialist referrals, and treating strength and conditioning as medical variables we monitor and adjust. It also means meeting metabolic disease — including obesity — as the chronic, hormonally driven condition it is, rather than a question of willpower. The tools have caught up. The practice patterns are what need to move.